foxo4-dri senolytic or senomorphic Peptide for Research Use Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI Results: What to Expect (2026) Assessment of senescence level in PDL9 cells after FOXO4 DRI treatment. Download Scientific Diagram
Pay in 4 interest-free payments of $6.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23




